Topic

Cigna

A collection of 1335 issues

If Pombiliti Isn't Approved by Cigna in California: Formulary Alternatives & Exception Paths

Quick Answer: Your Options When Cigna Denies Pombiliti If Cigna denies Pombiliti (cipaglucosidase alfa-atga) in California, Lumizyme or Nexviazyme are typically covered as first-line enzyme replacement therapies for late-onset Pompe disease. Most patients must try one of these alternatives before Cigna will consider Pombiliti approval. First step: Have your neurologist

How to Get Xyrem (Sodium Oxybate) Covered by Cigna in Illinois: Prior Authorization Guide and Appeals Process

Answer Box: Getting Xyrem Covered by Cigna in Illinois Fastest path to approval: Cigna requires prior authorization for Xyrem (sodium oxybate) with documented narcolepsy diagnosis, sleep study results, and failed trials of first-line treatments. Submit the Cigna Xyrem PA form with complete clinical documentation. If denied, you have 180 days

How to Get Breyanzi (lisocabtagene maraleucel) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Fastest Path to Breyanzi Coverage with Cigna in Pennsylvania To get Breyanzi (lisocabtagene maraleucel) covered by Cigna in Pennsylvania: (1) Have your CAR-T center submit prior authorization through Cigna's LifeSOURCE transplant program with complete documentation of diagnosis, prior therapy failures, and facility certification; (2) If denied,

How to Get Cystadane (Betaine Anhydrous) Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cystadane Approved by Cigna in New York Eligibility: Cystadane (betaine anhydrous) requires prior authorization from Cigna for homocystinuria with genetic/biochemical confirmation, specialist prescribing, and documented vitamin co-therapy plan. Fastest path: Submit PA through Cigna provider portal with genetic testing results, elevated homocysteine levels, and medical necessity

How to Get Taltz (Ixekizumab) Covered by Cigna in Pennsylvania: Prior Authorization Guide and Appeal Strategies

Answer Box: Getting Taltz (Ixekizumab) Covered by Cigna in Pennsylvania Cigna typically requires prior authorization and step therapy before approving Taltz (ixekizumab) for psoriasis, psoriatic arthritis, or ankylosing spondylitis. You'll usually need to try TNF inhibitors like adalimumab biosimilars or Enbrel first. If denied, Pennsylvania's new

How to Get Bavencio (Avelumab) Covered by Cigna in Illinois: Appeals Guide with Forms and Timelines

Answer Box: Getting Bavencio Covered by Cigna in Illinois Bavencio (avelumab) requires prior authorization from Cigna and must be dispensed through their specialty pharmacy Accredo. In Illinois, you have strong appeal rights including external review by an independent physician if denied. Start today: Have your oncologist submit a complete PA

How to Get Vigabatrin (Sabril) Covered by Cigna in Virginia: Complete Appeals Guide with Forms & Timelines

Answer Box: Getting Vigabatrin Covered by Cigna in Virginia Fastest path to approval: Complete Vigabatrin REMS enrollment for prescriber, patient, and pharmacy, then submit Cigna's prior authorization form with medical necessity documentation. If denied, file internal appeal within 180 days, followed by Virginia external review (Form 216-A) within

How to Get Vitrakvi (larotrectinib) Covered by Cigna in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Vitrakvi Covered by Cigna in Texas Eligibility: Vitrakvi (larotrectinib) requires prior authorization from Cigna for patients with NTRK gene fusion-positive solid tumors that are metastatic or unresectable. Fastest path to approval: Have your oncologist submit a prior authorization request through CignaforHCP.com with complete NTRK fusion testing

How to Get Rystiggo (Rozanolixizumab-noli) Covered by Cigna in California: Prior Authorization Guide and Appeal Scripts

Answer Box: To get Rystiggo (rozanolixizumab-noli) covered by Cigna in California, you need confirmed AChR- or MuSK-positive generalized myasthenia gravis and documented failure of standard therapies (pyridostigmine, corticosteroids, immunosuppressants). Submit prior authorization through CignaForHCP.com with complete treatment history. If denied, California's Independent Medical Review (IMR) through DMHC

Getting Tagrisso (Osimertinib) Covered by Cigna in New Jersey: Complete Guide to Prior Authorization and Appeals

Quick Answer: How to Get Tagrisso Covered by Cigna in New Jersey Cigna covers Tagrisso (osimertinib) with prior authorization for EGFR-mutated NSCLC in metastatic, adjuvant, and unresectable stage III settings. No step therapy required under Cigna's national policy. To get approved: (1) Submit PA with EGFR mutation test